WallStreetZenWallStreetZen

NASDAQ: MGRM
Monogram Technologies Inc Stock Forecast, Predictions & Price Target

OverviewForecast
EarningsRevenueDividendOwnership

Analyst price target for MGRM

Based on 1 analyst offering 12 month price targets for Monogram Technologies Inc

Min Forecast
$5.40+87.5%
Avg Forecast
$5.40+87.5%
Max Forecast
$5.40+87.5%

Should I buy or sell MGRM stock?

Based on 1 analyst offering ratings for Monogram Technologies Inc.

Strong Buy
Strong Buy
1 analysts 100%
Buy
0 analysts 0%
Hold
0 analysts 0%
Sell
0 analysts 0%
Strong Sell
0 analysts 0%
Although MGRM's forecast from analysts indicates a "Strong Buy", our proven Zen Rating quant model rates MGRM as a "Strong Sell". Stocks with a Zen Rating of Strong Sell have had an average return of -8.02% per year. Learn More

Be the first to know when Wall Street analysts revise their MGRM stock forecasts and price targets.

MGRM stock forecasts by analyst

Analyst / FirmRatingActionPrice TargetUpside/DownsideDateAnalyst Color
lockedlocked$00.00+00.00%2025-03-18

1 of 1

Forecast return on equity

Is MGRM forecast to generate an efficient return?

Company
4.87%
Industry
20.96%
Market
80.85%
MGRM's Return on Equity is... subscribe to Premium to read more.
Forecast High Return on Equity Forecast

Forecast return on assets

Is MGRM forecast to generate an efficient return on assets?

Company
3.97%
Industry
13.4%
MGRM is forecast to generate... subscribe to Premium to read more.
Forecast Return on Assets vs Industry Forecast

MGRM earnings per share forecast

What is MGRM's earnings per share in the next 3 years based on estimates from 2 analysts?

Avg 1 year Forecast
-$0.63
Avg 2 year Forecast
-$0.45
Avg 3 year Forecast
-$0.34

MGRM revenue forecast

What is MGRM's revenue in the next 3 years based on estimates from 1 analyst?

Avg 1 year Forecast
$5.7M
Avg 2 year Forecast
$13.4M
Avg 3 year Forecast
$58.0M

MGRM vs Medical Device Stocks

TickerPricePrice TargetUp/downsideConsensus
MGRM$2.88$5.40+87.50%Strong Buy
RPID$2.35$8.00+240.43%Strong Buy
ICAD$3.42N/AN/A
QIPT$2.17N/AN/A
ELUT$2.24$8.00+257.14%Strong Buy
View Top Medical Device Stocks

Monogram Technologies Stock Forecast FAQ

Is Monogram Technologies Stock a good buy in 2025, according to Wall Street analysts?

The consensus among 1 Wall Street analyst covering (NASDAQ: MGRM) stock is to Strong Buy MGRM stock.

Out of 1 analyst, 1 (100%) are recommending MGRM as a Strong Buy, 0 (0%) are recommending MGRM as a Buy, 0 (0%) are recommending MGRM as a Hold, 0 (0%) are recommending MGRM as a Sell, and 0 (0%) are recommending MGRM as a Strong Sell.

If you're new to stock investing, here's how to buy Monogram Technologies stock.

What is MGRM's earnings growth forecast for 2025-2027?

(NASDAQ: MGRM) Monogram Technologies's forecast annual earnings growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast earnings growth rate of 15.34%, and while it is not forecast to beat the US market's average forecast earnings growth rate of 17.6%.

Monogram Technologies's earnings in 2025 is -$16,479,000.On average, 2 Wall Street analysts forecast MGRM's earnings for 2025 to be -$22,055,903, with the lowest MGRM earnings forecast at -$28,584,450, and the highest MGRM earnings forecast at -$15,527,355. On average, 2 Wall Street analysts forecast MGRM's earnings for 2026 to be -$15,703,803, with the lowest MGRM earnings forecast at -$25,761,294, and the highest MGRM earnings forecast at -$5,646,311.

In 2027, MGRM is forecast to generate -$11,998,411 in earnings, with the lowest earnings forecast at -$11,998,411 and the highest earnings forecast at -$11,998,411.

What is MGRM's revenue growth forecast for 2025-2027?

(NASDAQ: MGRM) Monogram Technologies's forecast annual revenue growth rate of N/A is not forecast to beat the US Medical Devices industry's average forecast revenue growth rate of 8.28%, and while it is not forecast to beat the US market's average forecast revenue growth rate of 10.18%.

Monogram Technologies's revenue in 2025 is $0.On average, 1 Wall Street analysts forecast MGRM's revenue for 2025 to be $199,738,253, with the lowest MGRM revenue forecast at $199,738,253, and the highest MGRM revenue forecast at $199,738,253. On average, 2 Wall Street analysts forecast MGRM's revenue for 2026 to be $473,937,233, with the lowest MGRM revenue forecast at $473,231,444, and the highest MGRM revenue forecast at $474,643,022.

In 2027, MGRM is forecast to generate $2,047,140,646 in revenue, with the lowest revenue forecast at $2,047,140,646 and the highest revenue forecast at $2,047,140,646.

What is MGRM's forecast return on assets (ROA) for 2025-2028?

(NASDAQ: MGRM) forecast ROA is 3.97%, which is lower than the forecast US Medical Devices industry average of 13.4%.

What is MGRM's Price Target?

According to 1 Wall Street analyst that have issued a 1 year MGRM price target, the average MGRM price target is $5.40, with the highest MGRM stock price forecast at $5.40 and the lowest MGRM stock price forecast at $5.40.

The Wall Street analyst predicted that Monogram Technologies's share price could reach $5.40 by Mar 18, 2026. The average Monogram Technologies stock price prediction forecasts a potential upside of 87.5% from the current MGRM share price of $2.88.

What is MGRM's Earnings Per Share (EPS) forecast for 2025-2027?

(NASDAQ: MGRM) Monogram Technologies's current Earnings Per Share (EPS) is -$0.51. On average, analysts forecast that MGRM's EPS will be -$0.63 for 2025, with the lowest EPS forecast at -$0.81, and the highest EPS forecast at -$0.44. On average, analysts forecast that MGRM's EPS will be -$0.45 for 2026, with the lowest EPS forecast at -$0.73, and the highest EPS forecast at -$0.16. In 2027, MGRM's EPS is forecast to hit -$0.34 (min: -$0.34, max: -$0.34).

What is MGRM's forecast return on equity (ROE) for 2025-2028?

(NASDAQ: MGRM) forecast ROE is 4.87%, which is considered weak.
©2025 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.